sloto cash casino
Election To Hold In 20 LGAs, 37 LCDAs – Lagos APCAd industry’s depiction of men as dim-witted goofballs is anti-comedy
Croatia’s incumbent president wins most votes at polls but still faces runoff
Longest-lived US president was always happy to speak his mindCOLUMBUS, Ohio -- A brawl exploded Saturday between Michigan and Ohio State when the Wolverines planted their flag at midfield in the Horseshoe following their stunning 13-10 upset of the second-ranked Buckeyes. Police eventually used pepper spray to quash the scuffle that lasted roughly five minutes. Players and coaches from both sides were left bloodied from the pushing and shoving. As the Wolverines gathered on the Block O logo in celebration, several Ohio State players rushed in throwing punches. Michigan players punched back. Wolverines coach Sherrone Moore and Ohio State athletic director Ross Bjork were among those who tried to break up the multiple skirmishes that broke out. Several police officers eventually stepped in and attempted to form a line separating the two teams. Editor's Picks Michigan stuns Ohio St. for 4th straight in rivalry 19m Associated Press Saturday Shocker: Michigan shocks No. 2 Ohio State to lead top 2024 upsets 1h ESPN Staff Ohio State University police said in a statement that "officers from multiple law enforcement agencies assisted in breaking up an on-field altercation. During the scuffle, multiple officers representing Ohio and Michigan deployed pepper spray." Ohio State police said it will continue to investigate the incident. Buckeyes coach Ryan Day later blamed Michigan for starting the melee by planting the flag. "I don't know all the details of it, but I know these guys are looking to put a flag on our field and our guys weren't going to let that happen," Day said. "I'll find out exactly what happened. But this is our field and certainly we're embarrassed of the fact that we lost the game, but there's some prideful guys in this team that weren't going to just let that happen." Moore said he wished both teams handled the incident better. "It was emotions on both sides," Moore said. "I did see they had the flag and guys were waving it around and their guys charged us. There's emotion on both sides. It can't happen. Rivalry games get heated, especially this one, it's the biggest one in the country, so we got to handle that one better." The Wolverines came in as 20.5-point underdogs, the second-biggest spread in the rivalry dating back to 1978. But after a scoreless second half, Dominic Zvada nailed a 21-yard field goal with 45 seconds remaining, giving Michigan its fourth straight win in the series. Wolverines All-American defensive tackle Mason Graham and Ohio State defensive end Jack Sawyer emphatically traded insults as the incident finally waned, with several Michigan players waving bye to the Buckeyes as they finally walked away. Kaleel Mullings, who rushed for 116 yards and scored the Wolverines' only touchdown, called the Buckeyes "classless" for trying to fight afterward. "For such a great game, you hate to see stuff like that after the game," he said. "This is bad for the sport and bad for college football, but at the end of the day, some people have got to learn how to lose. You can't be fighting and stuff just because you lost a game. All that fighting -- we had 60 minutes, we had four quarters to do all that fighting, and now, people want to talk and fight. ... People have got to be better."
DALLAS (AP) — Juan Soto gets free use of a luxury suite and up to four premium tickets behind home plate for regular-season and postseason New York Mets home games as part of his record $765 million, 15-year contract that was finalized Wednesday. The Mets also agreed to provide personal team security for the All-Star outfielder and his family at the team’s expense for all spring training and regular-season home and road games, according to details of the agreement obtained by The Associated Press. Major League Baseball teams usually provide security for player families in seating areas at ballparks. New York also agreed to assist Soto's family for in-season travel arrangements, guaranteed Soto will have uniform No. 22 and included eight types of award bonuses. Soto's suite will be valued at the Mets' prevailing prices, presumably for tax purposes, and after 2025 he can by each Jan. 15 modify or give up his suite selection for the upcoming season. He can request the premium tickets, to be used by family members, no later than 72 hours before the scheduled game time. The Yankees had refused to offer Soto a free suite. “Some high-end players that make a lot of money for us, if they want suites they buy them ... whether it's CC (Sabathia), whether it’s (Aaron) Judge, whether it’s (Gerrit) Cole, whether it’s any of these guys," general manager Brian Cashman said. "We've gone through a process on previous negotiations where asks might have happened and this is what we did and we’re going to honor those, so no regrets there." Cashman said the Yankees have a shared suite for player families and a family room with babysitting. Soto gets a $75 million signing bonus, payable within 60 days of the agreement’s approval by the commissioner’s office. The deal for the 26-year-old, which tops Shohei Ohtani's $700 million, 10-year contract with the Dodgers, was reached Sunday pending a physical that took place Tuesday. Soto receives salaries of $46,875,000 each in 2025 and 2026, $42.5 million in 2027, $46,875,000 apiece in 2028 and 2029 and $46 million in each of the final 10 seasons. Soto has a contingent right to opt out of the agreement within three days of the end of the 2029 World Series to become a free agent again, but the Mets have the an option to negate the opt-out provision by increasing the yearly salaries for 2030-39 by $4 million annually to $50 million and raising the total value to $805 million. If the club exercises its option to negate the opt-out provision, Soto can make his opt-out decision by the fifth day after the World Series. He has a full no-trade provision and gets a hotel suite on road trips. Soto would receive a $500,000 bonus for winning his first Most Valuable Player award and $1 million for each MVP award. He would get $350,000 for finishing second in the voting and $150,000 for finishing third through fifth. Soto was third in the AL voting this year. He would earn $100,000 for each All-Star selection and Gold Glove, $350,000 for World Series MVP and $150,000 for League Championship Series MVP. Soto would get $100,000 for selection to the All-MLB first or second team, $150,000 for Silver Slugger and $100,000 for the Hank Aaron Award. Award bonuses are to be paid by the Jan. 31 after the season in which the bonus is earned. AP MLB: https://apnews.com/hub/mlbCyber Investment Firm, Option3, Names Longtime Bloomberg Executive Karl P. Kilb III as Operating Partner, and First Chief Strategy Officer at its Zero Trust Platform
Alexander: Is diminished USC-UCLA game another reminder of what we’ve lost?
Microsoft flags $0.8M writedown on stake in GM-backed CruiseIntech Investment Management LLC purchased a new position in shares of KalVista Pharmaceuticals, Inc. ( NASDAQ:KALV – Free Report ) during the third quarter, Holdings Channel.com reports. The fund purchased 10,855 shares of the specialty pharmaceutical company’s stock, valued at approximately $126,000. Other hedge funds have also recently added to or reduced their stakes in the company. Great Point Partners LLC purchased a new position in shares of KalVista Pharmaceuticals in the second quarter worth about $15,768,000. Emerald Advisers LLC increased its position in KalVista Pharmaceuticals by 29.8% during the third quarter. Emerald Advisers LLC now owns 835,988 shares of the specialty pharmaceutical company’s stock worth $9,681,000 after purchasing an additional 192,091 shares during the last quarter. Emerald Mutual Fund Advisers Trust increased its position in KalVista Pharmaceuticals by 23.0% during the third quarter. Emerald Mutual Fund Advisers Trust now owns 650,980 shares of the specialty pharmaceutical company’s stock worth $7,538,000 after purchasing an additional 121,615 shares during the last quarter. Susquehanna Fundamental Investments LLC increased its position in KalVista Pharmaceuticals by 323.5% during the second quarter. Susquehanna Fundamental Investments LLC now owns 68,526 shares of the specialty pharmaceutical company’s stock worth $807,000 after purchasing an additional 52,347 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in KalVista Pharmaceuticals by 21.0% during the second quarter. Bank of New York Mellon Corp now owns 135,600 shares of the specialty pharmaceutical company’s stock worth $1,597,000 after purchasing an additional 23,547 shares during the last quarter. Insider Buying and Selling at KalVista Pharmaceuticals In related news, insider Paul K. Audhya sold 8,077 shares of KalVista Pharmaceuticals stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $9.26, for a total value of $74,793.02. Following the completion of the transaction, the insider now owns 94,199 shares in the company, valued at approximately $872,282.74. The trade was a 7.90 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink . Also, CEO Benjamin L. Palleiko sold 14,400 shares of KalVista Pharmaceuticals stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $9.26, for a total transaction of $133,344.00. Following the completion of the transaction, the chief executive officer now owns 266,598 shares of the company’s stock, valued at $2,468,697.48. This represents a 5.12 % decrease in their position. The disclosure for this sale can be found here . Insiders sold a total of 32,016 shares of company stock worth $319,344 over the last three months. Insiders own 10.50% of the company’s stock. KalVista Pharmaceuticals Price Performance KalVista Pharmaceuticals ( NASDAQ:KALV – Get Free Report ) last announced its quarterly earnings results on Thursday, September 5th. The specialty pharmaceutical company reported ($0.87) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.91) by $0.04. As a group, sell-side analysts expect that KalVista Pharmaceuticals, Inc. will post -2.7 earnings per share for the current fiscal year. Wall Street Analysts Forecast Growth KALV has been the subject of several recent analyst reports. HC Wainwright restated a “buy” rating and set a $20.00 price objective on shares of KalVista Pharmaceuticals in a research report on Friday. Cantor Fitzgerald restated an “overweight” rating on shares of KalVista Pharmaceuticals in a research report on Monday, September 9th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $28.00 price target on shares of KalVista Pharmaceuticals in a research report on Thursday. View Our Latest Stock Report on KALV KalVista Pharmaceuticals Company Profile ( Free Report ) KalVista Pharmaceuticals, Inc, a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company’s product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). Featured Stories Want to see what other hedge funds are holding KALV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KalVista Pharmaceuticals, Inc. ( NASDAQ:KALV – Free Report ). Receive News & Ratings for KalVista Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KalVista Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .